Are clonazepam and alprazolam (Xanax) interchangeable on a 1:1 dosing basis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, clonazepam and alprazolam (Xanax) are NOT interchangeable on a 1:1 dosing basis

Clonazepam is approximately 2-4 times more potent than alprazolam, meaning you need significantly less clonazepam to achieve equivalent effects. The most commonly cited conversion in clinical practice is approximately 0.5 mg clonazepam = 1 mg alprazolam, though some sources suggest ratios ranging from 0.25-1 mg clonazepam per 1 mg alprazolam 1.

Key Pharmacokinetic Differences

These medications differ substantially in their clinical profiles:

Half-life differences:

  • Clonazepam: 30-40 hours (long-acting) 2
  • Alprazolam: ~12 hours (intermediate-acting) 3

This fundamental difference has major clinical implications. Clonazepam's longer half-life allows for less frequent dosing (typically 2-3 times daily versus alprazolam's 3-4 times daily) and provides more continuous anxiety control without interdose breakthrough symptoms 1, 4.

Practical Conversion Guidance

When switching from alprazolam to clonazepam:

Start conservatively: Use a 0.5:1 ratio (0.5 mg clonazepam for every 1 mg alprazolam) as your initial conversion 1. For example:

  • Alprazolam 1 mg TID → Clonazepam 0.5 mg BID-TID
  • Alprazolam 2 mg TID → Clonazepam 1 mg BID-TID

Perform gradual cross-taper: Do not abruptly switch. Gradually reduce alprazolam while simultaneously introducing clonazepam over 1-2 weeks to minimize withdrawal symptoms 5.

Monitor closely: The longer half-life of clonazepam means it takes 5-7 days to reach steady state, so full effects won't be apparent immediately 6.

Critical Clinical Considerations

Interdose anxiety: One major advantage of switching to clonazepam is elimination of interdose rebound anxiety that commonly occurs with alprazolam's shorter half-life. In one study, 82% of patients rated clonazepam "better" than alprazolam specifically because of decreased dosing frequency and lack of interdose anxiety 1.

Withdrawal risk: Alprazolam carries particularly high risk for severe withdrawal and rebound symptoms due to its rapid elimination 4, 7. The FDA label explicitly warns about withdrawal seizures and recommends reducing dosage by no more than 0.5 mg every 3 days 5. Clonazepam's longer half-life makes discontinuation somewhat easier, though still requires gradual tapering 2.

Side effect profile: Both medications cause sedation, but clonazepam's longer duration may cause more persistent morning sedation and cognitive impairment 2, 8. In elderly patients or those with neurodegenerative disease, start with 0.25 mg clonazepam 8.

Special populations: In geriatric patients, the FDA recommends starting alprazolam at 0.25 mg 2-3 times daily 5. For clonazepam in this population, also start at 0.25 mg but with less frequent dosing due to the longer half-life 8.

Common Pitfall to Avoid

Do not assume 1:1 equivalence. Using equal doses will result in over-sedation and increased fall risk, particularly in elderly patients. The American Geriatrics Society Beers Criteria lists clonazepam as potentially inappropriate in older adults specifically due to these risks 8.

References

Research

The alprazolam to clonazepam switch for the treatment of panic disorder.

Journal of clinical psychopharmacology, 1987

Guideline

best practice guide for the treatment of rem sleep behavior disorder (rbd).

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010

Research

A Review of Alprazolam Use, Misuse, and Withdrawal.

Journal of addiction medicine, 2018

Guideline

management of rem sleep behavior disorder: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2023

Related Questions

How should I switch a patient taking clonazepam 1 mg four times daily to alprazolam (Xanax)?
Can I stop alprazolam (Xanax) 0.5 mg and switch to clonazepam 0.5 mg once daily as needed, and what is the safest way to make this transition?
What dose of clonazepam is equivalent to alprazolam 1 mg taken three times daily?
Is it safe for my patient to take alprazolam (Xanax) and clonazepam concurrently?
What is the recommended method to transition a patient from clonazepam 1 mg three times daily to alprazolam (Xanax) extended‑release 2 mg?
What is the appropriate management for a patient with total cholesterol 225 mg/dL, triglycerides 228 mg/dL, HDL cholesterol 48 mg/dL, VLDL cholesterol 40 mg/dL, and LDL cholesterol 137 mg/dL who is currently taking rosuvastatin (generic) 20 mg daily?
What is the differential diagnosis for microscopic hematuria with minimal pyuria on urinalysis?
What corticosteroid preparation is equivalent to hydrocortisone suppositories for an adult patient with hemorrhoids who cannot use hydrocortisone suppositories?
What is the recommended treatment for oral candidiasis in a geriatric patient?
How is Zenker's diverticulum diagnosed and treated?
For a patient using a Tandem insulin pump with basal rates of 1.45 U/h at 12 AM, 1.00 U/h at 2 AM, 1.20 U/h at 6 AM, 1.70 U/h at 8 AM, and 1.50 U/h at 9 PM, an insulin‑to‑correction factor of 1 unit per 8 mg/dL, and a time‑in‑range of 54% with frequent hyperglycemia, what adjustments to basal rates or correction factor would improve time‑in‑range?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.